Associations of Physical Inactivity and COVID-19 Outcomes Among Subgroups.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
04 2023
Historique:
received: 26 07 2022
revised: 19 09 2022
accepted: 13 10 2022
pubmed: 18 12 2022
medline: 22 3 2023
entrez: 17 12 2022
Statut: ppublish

Résumé

Physical activity before COVID-19 infection is associated with less severe outcomes. The study determined whether a dose‒response association was observed and whether the associations were consistent across demographic subgroups and chronic conditions. A retrospective cohort study of Kaiser Permanente Southern California adult patients who had a positive COVID-19 diagnosis between January 1, 2020 and May 31, 2021 was created. The exposure was the median of at least 3 physical activity self-reports before diagnosis. Patients were categorized as follows: always inactive, all assessments at 10 minutes/week or less; mostly inactive, median of 0-60 minutes per week; some activity, median of 60-150 minutes per week; consistently active, median>150 minutes per week; and always active, all assessments>150 minutes per week. Outcomes were hospitalization, deterioration event, or death 90 days after a COVID-19 diagnosis. Data were analyzed in 2022. Of 194,191 adults with COVID-19 infection, 6.3% were hospitalized, 3.1% experienced a deterioration event, and 2.8% died within 90 days. Dose‒response effects were strong; for example, patients in the some activity category had higher odds of hospitalization (OR=1.43; 95% CI=1.26, 1.63), deterioration (OR=1.83; 95% CI=1.49, 2.25), and death (OR=1.92; 95% CI=1.48, 2.49) than those in the always active category. Results were generally consistent across sex, race and ethnicity, age, and BMI categories and for patients with cardiovascular disease or hypertension. There were protective associations of physical activity for adverse COVID-19 outcomes across demographic and clinical characteristics. Public health leaders should add physical activity to pandemic control strategies.

Identifiants

pubmed: 36528452
pii: S0749-3797(22)00526-8
doi: 10.1016/j.amepre.2022.10.007
pmc: PMC9750896
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

492-502

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2022 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Références

Ann Intern Med. 2021 Mar;174(3):362-373
pubmed: 33253040
Ann Intern Med. 2021 Aug;174(8):1183-1186
pubmed: 33872046
JAMA. 2022 Jan 18;327(3):211-212
pubmed: 34989789
Sports Med. 2021 Aug;51(8):1673-1686
pubmed: 33877614
Br J Sports Med. 2021 Oct;55(19):1099-1105
pubmed: 33849909
Prog Cardiovasc Dis. 2021 Jan-Feb;64:102-104
pubmed: 32278694
Br J Sports Med. 2022 Aug 22;:
pubmed: 35995587
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Health Soc Behav. 2010;51 Suppl:S15-27
pubmed: 20943580
JAMA Netw Open. 2021 Nov 1;4(11):e2134147
pubmed: 34762110
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Am J Prev Med. 2021 Jun;60(6):866-872
pubmed: 33781618
Am J Emerg Med. 2021 Aug;46:489-494
pubmed: 33189516
Prim Health Care Res Dev. 2016 May;17(3):265-76
pubmed: 26178779
Prev Chronic Dis. 2014 Dec 18;11:E219
pubmed: 25523350
Perm J. 2012 Summer;16(3):37-41
pubmed: 23012597
Med Sci Sports Exerc. 2012 Nov;44(11):2071-6
pubmed: 22688832
Front Aging Neurosci. 2019 Apr 26;11:98
pubmed: 31080412
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138
pubmed: 35085223
MMWR Morb Mortal Wkly Rep. 2021 Aug 20;70(33):1114-1119
pubmed: 34411075
J Phys Act Health. 2018 Dec 17;:1-11
pubmed: 30558473
MMWR Morb Mortal Wkly Rep. 2021 Apr 09;70(14):519-522
pubmed: 33830988
JAMA. 2018 Nov 20;320(19):2020-2028
pubmed: 30418471
Am J Lifestyle Med. 2021 Jul 27;16(4):420-433
pubmed: 35855783
Br J Sports Med. 2022 May;56(10):568-576
pubmed: 35140062
Ann Intern Med. 2020 Nov 17;173(10):773-781
pubmed: 32783686
Brain Behav Immun. 2020 Jul;87:6-7
pubmed: 32311497

Auteurs

Deborah Rohm Young (DR)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California. Electronic address: deborah.r.young@kp.org.

James F Sallis (JF)

University of California San Diego, San Diego, California; Australian Catholic University, Melbourne, Australia.

Aileen Baecker (A)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California.

Deborah A Cohen (DA)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California.

Claudia L Nau (CL)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California.

Gary N Smith (GN)

Economics Department, Pomona College, Claremont, California.

Robert E Sallis (RE)

Department of Family and Sports Medicine, Kaiser Permanente Medical Center, Fontana, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH